• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Profile of specific antibodies to SARS-CoV-2: The first report.

作者信息

Zeng Zhikun, Chen Liangjun, Pan Yunbao, Deng Qiaoling, Ye Guangming, Li Yirong, Wang Xinghuan

机构信息

Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.

Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.

出版信息

J Infect. 2020 Jul;81(1):e80-e81. doi: 10.1016/j.jinf.2020.03.052. Epub 2020 Apr 10.

DOI:10.1016/j.jinf.2020.03.052
PMID:32283140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7194903/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd04/7194903/dd9da3d62982/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd04/7194903/dd9da3d62982/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd04/7194903/dd9da3d62982/gr1_lrg.jpg

相似文献

1
Re: Profile of specific antibodies to SARS-CoV-2: The first report.关于：新型冠状病毒2019（SARS-CoV-2）特异性抗体的概况：首次报告。
J Infect. 2020 Jul;81(1):e80-e81. doi: 10.1016/j.jinf.2020.03.052. Epub 2020 Apr 10.
2
Profile of specific antibodies to SARS-CoV-2: The first report.新型冠状病毒2019（SARS-CoV-2）特异性抗体概况：首次报告
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.012. Epub 2020 Mar 21.
3
Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).无症状冠状病毒感染：中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2（新型冠状病毒肺炎）
Travel Med Infect Dis. 2020 May-Jun;35:101608. doi: 10.1016/j.tmaid.2020.101608. Epub 2020 Feb 27.
4
Re: Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and 'suppressing' the pandemic.关于：对计划进行手术的新冠肺炎（严重急性呼吸综合征冠状病毒2）患者的检测建议——持续提供服务并“遏制”疫情。
Br J Oral Maxillofac Surg. 2020 Jul;58(6):733. doi: 10.1016/j.bjoms.2020.05.012. Epub 2020 May 16.
5
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.轻度新冠患者体内抗新冠病毒抗体的丧失
N Engl J Med. 2020 Oct 22;383(17):1694-1695. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
6
The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体在冠状病毒病（COVID-19）中的作用：多数情况下促进康复，有时也会造成损害。
Respirology. 2020 Jul;25(7):680-682. doi: 10.1111/resp.13852. Epub 2020 May 20.
7
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.轻度新冠肺炎中抗SARS-CoV-2抗体的丧失。回复。
N Engl J Med. 2020 Oct 22;383(17):1697-1698. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
8
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.轻度新冠病毒感染中抗新冠病毒-2抗体的丧失
N Engl J Med. 2020 Oct 22;383(17):1695-1696. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
9
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.轻症新冠患者体内抗SARS-CoV-2抗体的丧失
N Engl J Med. 2020 Oct 22;383(17):1695. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
10
From SARS-CoV to SARS-CoV-2: The response and challenge of forensic infectious disease autopsy.从严重急性呼吸综合征冠状病毒到严重急性呼吸综合征冠状病毒2：法医传染病尸检的应对与挑战
Fa Yi Xue Za Zhi. 2020 Feb;36(1):1-3. doi: 10.12116/j.issn.1004-5619.2020.01.001. Epub 2020 Feb 25.

引用本文的文献

1
The correlation between humoral immune responses and severity of clinical symptoms in COVID-19 patients.新冠病毒肺炎患者体液免疫反应与临床症状严重程度之间的相关性。
Epidemiol Infect. 2023 Sep 11;151:e158. doi: 10.1017/S0950268823001437.
2
Comparative Analysis of Antimicrobial Antibodies between Mild and Severe COVID-19.轻症与重症 COVID-19 患者的抗菌抗体比较分析。
Microbiol Spectr. 2023 Aug 17;11(4):e0469022. doi: 10.1128/spectrum.04690-22. Epub 2023 Jun 6.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.

本文引用的文献

1
Profile of specific antibodies to SARS-CoV-2: The first report.新型冠状病毒2019（SARS-CoV-2）特异性抗体概况：首次报告
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.012. Epub 2020 Mar 21.
2
Positive RT-PCR Test Results in Patients Recovered From COVID-19.新冠病毒感染者康复后出现 RT-PCR 检测结果阳性。
JAMA. 2020 Apr 21;323(15):1502-1503. doi: 10.1001/jama.2020.2783.
3
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown.武汉封城期间当地疫区患者 SARS-CoV-2 抗体监测。
BMC Infect Dis. 2022 Jan 4;22(1):10. doi: 10.1186/s12879-021-07010-w.
5
Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19.实验室检测结果在 COVID-19 的预防、诊断、治疗和监测中的应用。
Signal Transduct Target Ther. 2021 Aug 25;6(1):316. doi: 10.1038/s41392-021-00731-z.
6
High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study.严重急性呼吸综合征冠状病毒2 N蛋白抗原化学发光免疫测定在新型冠状病毒肺炎急性期诊断一线检测中的高性能：一项回顾性队列研究
Front Med (Lausanne). 2021 Jul 14;8:676560. doi: 10.3389/fmed.2021.676560. eCollection 2021.
7
Mass SARS-CoV-2 molecular and serological screening of medical staff and patients in Hangzhou, China: no evidence of RNA detection, low seroprevalence, and limited exposure risk in the hospital setting.对中国杭州医护人员和患者进行的大规模新冠病毒分子和血清学筛查：在医院环境中未发现RNA检测证据、血清阳性率低且暴露风险有限。
Ann Transl Med. 2021 Apr;9(7):552. doi: 10.21037/atm-20-7163.
8
Review of the Microbiological Diagnostic Approaches of COVID-19.新冠病毒（COVID-19）微生物诊断方法综述。
Front Public Health. 2021 Apr 27;9:592500. doi: 10.3389/fpubh.2021.592500. eCollection 2021.
9
SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients.SARS-CoV-2 全蛋白组分析揭示了 COVID-19 患者中显著的抗原表位特征。
Front Immunol. 2021 Mar 23;12:629185. doi: 10.3389/fimmu.2021.629185. eCollection 2021.
10
Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand.新西兰新冠病毒抗体动态的综合分析
Clin Transl Immunology. 2021 Mar 14;10(3):e1261. doi: 10.1002/cti2.1261. eCollection 2021.
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
4
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak.基于 RNA 的宏基因组二代测序（mNGS）方法从 2019 年武汉暴发的两例肺炎个体病例中鉴定出一种新型人类冠状病毒。
Emerg Microbes Infect. 2020 Feb 5;9(1):313-319. doi: 10.1080/22221751.2020.1725399. eCollection 2020.
5
The Immunobiology of SARS*.严重急性呼吸综合征的免疫生物学*
Annu Rev Immunol. 2007;25:443-72. doi: 10.1146/annurev.immunol.25.022106.141706.
6
Neutralizing antibody response and SARS severity.中和抗体反应与SARS严重程度。
Emerg Infect Dis. 2005 Nov;11(11):1730-7. doi: 10.3201/eid1111.040659.
7
Profile of specific antibodies to the SARS-associated coronavirus.严重急性呼吸综合征相关冠状病毒特异性抗体概况
N Engl J Med. 2003 Jul 31;349(5):508-9. doi: 10.1056/NEJM200307313490520.